Analysis of related factors of portal vein thrombosis in liver cirrhosis

被引:4
|
作者
Xu, Xiaotong [1 ]
Jin, Jinglan [1 ]
Liu, Yuwei [1 ]
Li, Hang [1 ]
机构
[1] Jilin Univ, Dept Hepatol, Hosp 1, Changchun, Peoples R China
关键词
Liver cirrhosis; Portal vein thrombosis; Thromboelastography; IL-6; TNF-alpha; INFLAMMATION;
D O I
10.1186/s12876-022-02632-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aims To investigate the usefulness of interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), protein C (PC), and thromboelastography (TEG) to serve as a predictor of portal vein thrombosis (PVT) in patients with liver cirrhosis. Additionally, we examined the clinical significance of the above indicators in terms of disease progression. Methods A total of 123 patients with liver cirrhosis were recruited from May 2021 to December 2021, according to the imaging findings. They were divided into the PVT group (n = 52) and the non-PVT group (n = 71). Furthermore, patients with PVT were divided into plasma transfusion groups (n = 13) and non-plasma transfusion groups (n = 39). The basic general information, past medical history, laboratory, and imaging examination data were collected and analyzed. Results In univariate analysis, there was no significant difference between the two groups in IL-6, PC, reaction time (R), alpha angle (Angle), maximum amplitude, or coagulation index (CI) (P > 0.05). TNF-alpha in the PVT group was significantly lower than that in the non-PVT group (P = 0.001). K-time (K) in the PVT group was significantly higher than that in the non-PVT group (P = 0.031). There was no significant difference in IL-6, TNF-alpha, PC, or TEG between different Child-Pugh classification groups (P > 0.05). There were no significant differences in TEG between the plasma transfusion group and the non-plasma transfusion group. In Binary logistic regression analysis, TNF-alpha (OR = 0.9881, 95%CI = 0.971, 0.990, P < 0.001), K(OR = 1.28, 95% = 1.053, 1.569, P = 0.014), activate partial thromboplastin time (APTT) (OR = 0.753, 95%CI = 0.656, 0.865, P < 0.001), portal vein diameter (OR = 1.310, 95%CI = 1.108, 1.549, P = 0.002)and the history of splenectomy or embolism (OR = 7.565, 95%CI = 1.514, 37.799, P = 0.014)were related to the formation of PVT. Conclusions TNF-alpha, K, APTT, portal vein diameter, and splenectomy or embolism history were associated with PVT formation, but IL-6 was not.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Analysis of related factors of portal vein thrombosis in liver cirrhosis
    Xiaotong Xu
    Jinglan Jin
    Yuwei Liu
    Hang Li
    [J]. BMC Gastroenterology, 23
  • [2] ANALYSIS OF RELEVANT FACTORS OF PORTAL VEIN THROMBOSIS IN LIVER CIRRHOSIS
    Jin, Jinglan
    Xu, Xiaotong
    Liu, Yuwei
    Li, Hang
    Li, Yaya
    [J]. HEPATOLOGY, 2023, 78 : S1378 - S1379
  • [3] Analysis of factors related to recanalization of portal vein thrombosis in liver cirrhosis: a retrospective cohort study
    Shi, Yali
    Feng, Wanlin
    Cai, Jiaman
    Wang, Zhonglin
    Pu, Ying
    Mao, Weiting
    Zhan, Ke
    Chen, Daorong
    [J]. BMC GASTROENTEROLOGY, 2024, 24 (01)
  • [4] Portal vein thrombosis in liver cirrhosis
    Kinjo, Nao
    Kawanaka, Hirofumi
    Akahoshi, Tomohiko
    Matsumoto, Yoshihiro
    Kamori, Masahiro
    Nagao, Yoshihiro
    Hashimoto, Naotaka
    Uehara, Hideo
    Tomikawa, Morimasa
    Shirabe, Ken
    Maehara, Yoshihiko
    [J]. WORLD JOURNAL OF HEPATOLOGY, 2014, 6 (02) : 64 - 71
  • [5] Portal vein thrombosis in liver cirrhosis
    Nao Kinjo
    Hirofumi Kawanaka
    Tomohiko Akahoshi
    Yoshi-hiro Matsumoto
    Masahiro Kamori
    Yoshihiro Nagao
    Naotaka Hashimoto
    Hideo Uehara
    Morimasa Tomikawa
    Ken Shirabe
    Yoshihiko Maehara
    [J]. World Journal of Hepatology, 2014, 6 (02) : 64 - 71
  • [6] Hypercoagulability in portal vein thrombosis is related to the presence of liver cirrhosis
    Rajani, Rupesh
    Chaireti, Roza
    Bergquist, Annika
    Melin, Tor
    Friis-Liby, Ingalill
    Kapraali, Marjo
    Kechagias, Stergios
    Lindahl, Tomas L.
    Almer, Sven
    [J]. HEPATOLOGY, 2013, 58 : 883A - 883A
  • [7] Portal vein thrombosis in liver cirrhosis
    Fimognari, Filippo Luca
    Violi, Francesco
    [J]. INTERNAL AND EMERGENCY MEDICINE, 2008, 3 (03) : 213 - 218
  • [8] Portal vein thrombosis in liver cirrhosis
    Filippo Luca Fimognari
    Francesco Violi
    [J]. Internal and Emergency Medicine, 2008, 3 : 213 - 218
  • [9] The risk factors of portal vein thrombosis in patients with liver cirrhosis
    Cagin, Yasir Furkan
    Bilgic, Yilmaz
    Berber, Ilhami
    Yildirim, Oguzhan
    Erdogan, Mehmet Ali
    Firat, Feyza
    Arslan, Ahmet Kadir
    Colak, Cemil
    Seckin, Yuksel
    Harputluoglu, Murat
    [J]. EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 17 (04) : 3189 - 3194
  • [10] Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis
    Gómez, MR
    García, ES
    Lacomba, DL
    Marchante, I
    Grande, L
    Fernandez, MC
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2000, 31 (03) : 237 - 240